一项多中心、随机、双盲、平行对照临床研究——评价酒石酸美托洛尔片联合通脉养心丸治疗室性早搏的有效性和安全性

doi:10.3969/j.issn.1006-7795.2019.03.013

摘要/Abstract

摘要： 目的研究酒石酸美托洛尔片联合通脉养心丸对室性早搏的治疗作用。方法 584例室性早搏患者采用数字表法随机分成两组：试验组（n=292）：酒石酸美托洛尔片（1片/次，2次/d）联合通脉养心丸（40丸/次，2次/d）；对照组（n=292）：酒石酸美托洛尔片（1片/次，2次/d）联合通脉养心丸模拟剂（40丸/次，2次/d）；疗程均为8周。结果经过8周治疗后，试验组早搏次数下降4 537次，下降率为（63±53）%，治疗总有效率为76.4%，对照组早搏次数下降3 013次，下降率为（42±64）%，治疗总有效率为51.4%，两组患者室性早搏次数比较，差异有统计学意义（P<0.05）。两组患者不良事件和不良反应发生率比较，差异无统计学意义（P>0.05）。结论酒石酸美托洛尔片联合通脉养心丸对室性早搏的治疗作用显著，能明显减少患者的室性早搏次数。

关键词: 酒石酸美托洛尔片, 通脉养心丸, 室性早搏

Abstract: Objective To investigated the effects of metoprolol tartrate tablets combined with tongmai yangxin pill (TMYXP) on premature ventricular contraction (PVC). Methods The 584 patients with PVC were randomly assigned at a 1:1 ratio into 2 groups:the treatment group (n=292, metoprolol tartrate tablets 2 tablets/d combined with TMYXP 80 pills/d) and the control group (n=292, metoprolol tartrate tablets 2 tablets/d combined with simulant TMYXP 80 pills/d). The total study period was 8 weeks.Results After treatment, the number of PVC in the treatment group decreased by 4 537 times, with a decrease rate of (63 ±53)%, and the total effective rate was 76.4%. The number of PVC in the control group decreased by 3 013 times, with a decrease rate of (42 ±64)%, and the total effective rate was 51.4%. The difference between the two groups was statistically significant (P<0.05). There was no significant difference in the incidence of adverse events and adverse reactions between the two groups (P>0.05). Conclusion Metoprolol tartrate tablets combined with TMYXP could effectively reduce the number of PVC.

Key words: metoprolol tartrate tablets, tongmai yangxin pill, premature ventricular contraction

中图分类号:

R541.7

孙希鹏, 诸国华, 罗鸿宇, 刘荣坤, 杨峥, 李静, 徐津鹏, 耿彤, 张恺骅, 华琦. 一项多中心、随机、双盲、平行对照临床研究——评价酒石酸美托洛尔片联合通脉养心丸治疗室性早搏的有效性和安全性[J]. 首都医科大学学报, 2019, 40(3): 389-395.

Sun Xipeng, Zhu Guohua, Luo Hongyu, Liu Rongkun, Yang Zheng, Li Jing, Xu Jinpeng, Geng Tong, Zhang Kaihua, Hua Qi. A multicenter, randomized, double-blind, parallel controlled clinical study: evaluate the efficacy and safety of metoprolol tartrate tablets combined with tongmai yangxin pill on premature ventricular contraction[J]. Journal of Capital Medical University, 2019, 40(3): 389-395.

参考文献

[1] Lee A K, Deyell M W. Premature ventricular contraction-induced cardiomyopathy[J]. Curr Opin Cardiol, 2016,31(1):1-10.
[2] Nakamura H. Recent progress in molecular etiology of arrhythmia and anti-arrhythmia drug therapy[J]. Masui, 2004,53 Suppl:S81-90.
[3] Giannopoulos G, Kossyvakis C, Angelidis C, et al. Coincidental ganglionated plexus modification during radiofrequency pulmonary vein isolation and post-ablation arrhythmia recurrence[J]. Europace, 2017,19(12):1967-1972.
[4] Masri A, Hammadah M, Adelstein E, et al. Implantable cardioverter defibrillator in non-ischemic cardiomyopathy:a meta-analysis of randomized controlled trials[J]. Cardiovasc Diagn Ther, 2017,7(4):397-404.
[5] 郑蕊,陈静,樊官伟,等.潜在恶性心律失常治疗进展及中医药防治特点与前景[J].中医杂志,2015,56(18):1615-1618.
[6] 申琳,甘井山.缓慢性心律失常中医治疗研究进展[J].天津药学, 2015, 27(6):51-53.
[7] 陶珊,梁欣莹,王怡,等.通脉养心丸中心肌保护活性物质的筛选[J].浙江大学学报,2015,44(2):145-153.
[8] 蔡小军,王怡,胡利民.通脉养心丸对实验性心律失常的保护作用[J].世界中医药, 2010,5(6):425-426.
[9] 陈芹. 特发性右心室流出道室性早搏的发生与自主神经功能的关系分析[J].解放军医药杂志,2018,30(3):28-30.
[10] 叶茂, 罗贵全,何小君,等.射频导管消融术对不同起源频发室性早搏患者左心房功能的影响[J].解放军医药杂志,2018,30(12):68-72.
[11] Camm A J. Hopes and disappointments with antiarrhythmic drugs[J]. Int J Cardiol, 2017,237:71-74.
[12] Zhong L, Lee Y H, Huang X M, et al. Relative efficacy of catheter ablation vs antiarrhythmic drugs in treating premature ventricular contractions:a single-center retrospective study[J]. Heart Rhythm, 2014,11(2):187-193.
[13] 李林.加味炙甘草汤治疗室性早搏85例临床疗效观察[J].中医临床研究,2015,7(16):97-99.
[14] 吴华慧,周亚滨.养心汤治疗室性期前收缩患者的疗效观察[J].中医药学报,2012,40(3):169-170.
[15] 王文颖,高洪春.高洪春教授运用生脉散加减治疗气阴两虚型室性早搏的经验[J].云南中医中药杂志,2014,35(8):11-12.
[16] 丁林宝,晏飞,惠仪.葛根虎杖汤治疗室性早搏疗效观察[J].上海中医药杂志,2015,49(1):49-50.
[17] 高宇,包立新,孙彬,等.血府逐瘀汤加减治疗室性早搏疗效观察[J].临床医药文献杂志,2015,2(26):5523-5526.
[18] 芦波,刘莉.芪桂消早汤治疗冠心病室性早搏临床疗效分析[J].中国中医药信息杂志,2012,19(12):71-72.
[19] 周素芳,王先喜.通心络胶囊治疗冠心病过早搏动25例疗效观察[J].中原医刊,2002,29(6):45-46.
[20] 孙国栋.参松养心胶囊治疗室性早搏50例临床观察[J].浙江中医杂志,2014,49(2):110.
[21] 李丽华,葛晓励,韩林华,等.胺碘酮-联合稳心颗粒治疗频发室性早搏的临床疗效观察[J].河北联合大学学报:医学版,2012,14(3):353.
[22] 周旭.天王补心丹治疗室性早搏(阴虚火旺型)46例[J].中国中医药现代远程教育,2015,13(12):50-51.
[23] Abou el Ela Ael S, Allam A A, Ibrahim E H. Pharmacokinetics and anti-hypertensive effect of metoprolol tartrate rectal delivery system[J]. Drug Deliv, 2016,23(1):69-78.
[24] Newland A M, Mauro V F, Alexander K S. Physical compatibility of metoprolol tartrate injection with selected cardiovascular agents[J]. Am J Health Syst Pharm, 2009,66(11):986-987.
[25] Go A S, Yang J, Gurwitz J H, et al. Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure[J]. Am J Cardiol, 2007,100(4):690-696.
[26] Metra M, Torp-Pedersen C, Swedberg K, et al. Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure:results from the COMET trial[J]. Eur Heart J, 2005,26(21):2259-2268.
[27] 赵斌. 通脉养心丸的药理作用研究[J].科学与财富,2017(8):166.
[28] Fan Y, Man S, Li H, et al. Analysis of bioactive components and pharmacokinetic study of herb-herb interactions in the traditional Chinese patent medicine Tongmai Yangxin Pill[J]. J Pharm Biomed Anal,2016,120:364-373.
[29] Liu N, Li L, Zhu X, et al. A high content screening assay to identify compounds with anti-epithelial-mesenchymal transition effects from the Chinese herbal medicine tong-mai-yang-xin-wan[J]. Molecules, 2016, 21(10):1340.
[30] Tao S, Huang Y, Chen Z, et al. Rapid identification of anti-inflammatory compounds from Tongmai Yangxin Pills by liquid chromatography with high-resolution mass spectrometry and chemometric analysis[J].J Sep Sci,2015,38(11):1881-1893.
[31] 王巨会. 通脉养心丸联合倍他乐克治疗室性早搏的疗效评价[J]. 现代中西医结合杂志,2016,25(14):1563-1565.
[32] 刁艳菲. 通脉养心丸联合美托洛尔治疗冠心病心绞痛的临床观察[J]. 中西医结合心血管病杂志,2018,6(2):58.